Literature DB >> 26172318

Subtle visuomotor difficulties in preclinical Alzheimer's disease.

Maria A Mollica1, Jordi Navarra2, Irune Fernández-Prieto2,3,4, Jaume Olives1, Adrià Tort1, Natalia Valech1, Nina Coll-Padrós1, José L Molinuevo1,5, Lorena Rami1,5.   

Abstract

BACKGROUND: Individuals with preclinical Alzheimer's disease (Pre-AD) present nonimpaired cognition, as measured by standard neuropsychological tests. However, detecting subtle difficulties in cognitive functions may be necessary for an early diagnosis and intervention.
OBJECTIVES: A new computer-based visuomotor coordination task (VMC) was developed to investigate the possible presence of early visuomotor difficulties in Pre-AD individuals. Associations between VMC task performance and AD biomarkers were studied. The influence of ApoE status on participants' performance was addressed, as well as the relationship between performance and subjective cognitive decline (SCD).
METHODS: Sixty-six cognitively normal (CN) elders (19 Pre-AD and 47 control participants [CTR]) and 15 patients with AD performed the VMC task, which consisted in executing visually guided goal-directed movements that required the coordination of the visual and motor systems. All participants underwent ApoE analysis and lumbar puncture. CN participants also completed an extensive standard neuropsychological battery.
RESULTS: Despite presenting normal cognition in standard tests, Pre-AD participants exhibited higher response times (RTs) to complete the VMC task than CTR (p < .01). Besides, patients with AD showed higher RTs than CTR (p < .001) and Pre-AD (p < .05), and more errors than CTR (p < .005). RTs in ApoE4 carriers were higher than that observed in ApoE4 noncarriers (p < .01). In CN individuals, RTs were related to amyloid β-protein 42 (AB42) biomarker (p < .01) and informant-rated SCD (p < .01).
CONCLUSIONS: The VMC task is able to discriminate Pre-AD from CTR individuals. Moreover, VMC results are associated with AB42 levels in CN individuals, suggesting that visuomotor dysfunction may be a sensitive marker of Pre-AD.
© 2015 The British Psychological Society.

Entities:  

Keywords:  Alzheimer disease; ApoE; Visual Motor Coordination; biomarkers; task performance

Mesh:

Substances:

Year:  2015        PMID: 26172318     DOI: 10.1111/jnp.12079

Source DB:  PubMed          Journal:  J Neuropsychol        ISSN: 1748-6645            Impact factor:   2.864


  6 in total

1.  Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers.

Authors:  Sarah H Stout; Ganesh M Babulal; Chunyu Ma; David B Carr; Denise M Head; Elizabeth A Grant; Monique M Williams; David M Holtzman; Anne M Fagan; John C Morris; Catherine M Roe
Journal:  Alzheimers Dement       Date:  2018-01-10       Impact factor: 21.566

2.  Peripheral reaching in Alzheimer's disease and mild cognitive impairment.

Authors:  Alexandra G Mitchell; Stephanie Rossit; Suvankar Pal; Michael Hornberger; Annie Warman; Elise Kenning; Laura Williamson; Rebecca Shapland; Robert D McIntosh
Journal:  Cortex       Date:  2022-01-31       Impact factor: 4.027

3.  The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.

Authors:  Jane Alty; Quan Bai; Renjie Li; Katherine Lawler; Rebecca J St George; Edward Hill; Aidan Bindoff; Saurabh Garg; Xinyi Wang; Guan Huang; Kaining Zhang; Kaylee D Rudd; Larissa Bartlett; Lynette R Goldberg; Jessica M Collins; Mark R Hinder; Sharon L Naismith; David C Hogg; Anna E King; James C Vickers
Journal:  BMC Neurol       Date:  2022-07-18       Impact factor: 2.903

4.  Subjective cognitive impairment, cognitive disorders and self-perceived health: The importance of the informant.

Authors:  Mariana Luciano de Almeida; Daniela Dalpubel; Estela Barbosa Ribeiro; Eduardo Schneider Bueno de Oliveira; Juliana Hotta Ansai; Francisco Assis Carvalho Vale
Journal:  Dement Neuropsychol       Date:  2019 Jul-Sep

Review 5.  Digital Cognitive Biomarker for Mild Cognitive Impairments and Dementia: A Systematic Review.

Authors:  Zihan Ding; Tsz-Lok Lee; Agnes S Chan
Journal:  J Clin Med       Date:  2022-07-19       Impact factor: 4.964

Review 6.  Retinal Degeneration and Alzheimer's Disease: An Evolving Link.

Authors:  Ajay Ashok; Neena Singh; Suman Chaudhary; Vindhya Bellamkonda; Alexander E Kritikos; Aaron S Wise; Neil Rana; Dallas McDonald; Rithvik Ayyagari
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.